Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Latest News

EMR grows but lags, investor considerations

Emerson Electric (EMR) concluded the latest trading session at $110.28, marking a +0.44% change from the previous day’s closing price. Notably, the stock lagged behind the S&P 500, which exhibited a daily gain of 1.03%. Meanwhile, the Dow experienced a rise of 0.34%, and the Nasdaq, dominated by technology, saw an increase of 1.51%.

Over the past month, EMR shares gained 5.49%, outpacing the Industrial Products sector’s 5.61% increase and the S&P 500’s 3.21% gain in the same period.

Investors are closely monitoring Emerson Electric’s upcoming earnings release, with projected EPS at $1.24, indicating a 13.76% increase from the same quarter last year. Additionally, the consensus estimate forecasts revenue of $4.27 billion, reflecting a 13.74% upward movement from the corresponding quarter last year.

Looking at the full year, EMR Consensus Estimates anticipate earnings of $5.41 per share and revenue of $17.53 billion, marking changes of +21.85% and +15.61%, respectively, from the previous year.

Recent modifications to analyst estimates for Emerson Electric suggest shifting business trends, potentially influencing the stock price. The Emerson Electric (EMR) concluded the latest trading session at $110.28, marking a +0.44% change from the previous day’s closing price. Notably, the stock lagged behind the S&P 500, which exhibited a daily gain of 1.03%. Meanwhile, the Dow experienced a rise of 0.34%, and the Nasdaq, dominated by technology, saw an increase of 1.51%.

Over the past month, EMR shares gained 5.49%, outpacing the Industrial Products sector’s 5.61% increase and the S&P 500’s 3.21% gain in the same period.

Investors are closely monitoring Emerson Electric’s upcoming earnings release, with projected EPS at $1.24, indicating a 13.76% increase from the same quarter last year. Additionally, the consensus estimate forecasts revenue of $4.27 billion, reflecting a 13.74% upward movement from the corresponding quarter last year.

Looking at the full year, EMR Consensus Estimates anticipate earnings of $5.41 per share and revenue of $17.53 billion, marking changes of +21.85% and +15.61%, respectively, from the previous year.

Recent modifications to analyst estimates for Emerson Electric suggest shifting business trends, potentially influencing the stock price. The EMR Rank, a proven rating system, currently designates EMR as a #2 (Buy), with a track record of success in stocks rated #1 (Strong Buy), delivering an average annual return of +25% since 1988. Over the past month, the EMR Consensus EPS estimate for EMR has risen by 2.2%.

In terms of valuation, Emerson Electric trades at a Forward P/E ratio of 20.29, representing a discount compared to the industry’s average Forward P/E of 21.49. The PEG ratio, considering expected earnings growth, stands at 1.9, below the industry average of 1.95.

Situated in the Manufacturing – Electronics industry within the Industrial Products sector, EMR’s industry currently holds a EMR Industry Rank of 39, placing it in the top 16% of all industries. EMR Industry Rank, based on the average EMR Rank of individual stocks within the industry, indicates that top-rated industries outperform the bottom half by a factor of 2 to 1.

Stay informed about these influential metrics and more on  emrindustry.com.

EMR Investment Research Rank, a proven rating system, currently designates EMR as a #2 (Buy), with a track record of success in stocks rated #1 (Strong Buy), delivering an average annual return of +25% since 1988. Over the past month, the EMR Consensus EPS estimate for EMR has risen by 2.2%.

In terms of valuation, Emerson Electric trades at a Forward P/E ratio of 20.29, representing a discount compared to the industry’s average Forward P/E of 21.49. The PEG ratio, considering expected earnings growth, stands at 1.9, below the industry average of 1.95.

Situated in the Manufacturing – Electronics industry within the Industrial Products sector, EMR’s industry currently holds a EMR Industry Rank of 39, placing it in the top 16% of all industries. EMR Industry Rank, based on the average EMR Rank of individual stocks within the industry, indicates that top-rated industries outperform the bottom half by a factor of 2 to 1.

Stay informed about these influential metrics and more on  emrindustry.com.

EMR Investment Research